2010
DOI: 10.1007/s11094-010-0443-4
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of drug polymorphs (a review)

Abstract: Data available in the literature concerning the screening and preparation of drug polymorphs are reviewed. The most effective methods used to obtain polymorphous modifications of drug substances are based on crystallization. Crystallization of polymorphs is governed by both thermodynamic and kinetic factors; therefore, the preparation of certain drug polymorphs requires strict control of the crystallization conditions. Metastable modifications of drugs can be prepared predominantly using non-equilibrium crysta… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(7 citation statements)
references
References 72 publications
0
7
0
Order By: Relevance
“…Novel processes for the preparation of different polymorphs, apart from crystallization, are patented and published . Appropriate characterization techniques are needed to guide a chemist in the selection of a polymorph for final development after the discovery of polymorphic species.…”
Section: Introductionmentioning
confidence: 99%
“…Novel processes for the preparation of different polymorphs, apart from crystallization, are patented and published . Appropriate characterization techniques are needed to guide a chemist in the selection of a polymorph for final development after the discovery of polymorphic species.…”
Section: Introductionmentioning
confidence: 99%
“…Usually, different polymorphic forms possess different physicochemical and, as a consequence, biological properties (bioavailability, dissolution rate, etc. ). An undesired polymorphic transition can crucially influence the drug quality as occurred with ritonavir (the trademark is Norvir) . Therefore, an in-depth study of the polymorphism of an active pharmaceutical ingredient (API) aims not only at protecting the patent of a drug but also at choosing the most appropriate polymorphic form according to the combination of several factors such as manufacturability, stability, biological activity, reproducibility, etc. , …”
Section: Introductionmentioning
confidence: 99%
“…In many cases, crystallization from different solvents brings about the formation of different polymorphs. ,, It is known that variation of molecular positions and/or molecular conformation inside three-dimensional (3D) crystalline space brings significant variation of crystal properties. In the case of pharmaceutically active compounds, it is important to mention the differences in polymorph thermal stability, melting points, solubility, and bioavailability. For potential nonlinear optical (NLO) polymorphic materials, thermal stability is also important, but in this case, the molecular packing mode in crystals is more important since only acentric crystals can produce second-order NLO effects. The influence of molecular packing in polymorphs on electrical, magnetic, and spectral properties are important for many materials, including charge transfer (CT) materials, that can be used in organic light-emitting diodes (OLEDs), photovoltaic, and biomedical devices. …”
Section: Introductionmentioning
confidence: 99%